Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)

The introduction of direct oral anticoagulants (DOACs), such as dabigatran, rivaroxaban, apixaban, edoxaban, and betrixaban, provides safe and effective alternative to previous anticoagulant therapies. DOACs directly, selectively, and reversibly inhibit factors IIa or Xa. The coagulation effect foll...

Descripción completa

Detalles Bibliográficos
Autor principal: Dunois, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143174/
https://www.ncbi.nlm.nih.gov/pubmed/33919121
http://dx.doi.org/10.3390/biomedicines9050445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143174/
https://www.ncbi.nlm.nih.gov/pubmed/33919121
http://dx.doi.org/10.3390/biomedicines9050445

Ejemplares similares